Skip to content

Clinical and Radiographic Evaluation of Ridge Splitting With Simultaneous Implant Placement Covered With Concentrated Growth Factor Membranes in Narrow Alveolar Ridge

Clinical and Radiographic Evaluation of Ridge Splitting With Simultaneous Implant Placement Covered With Concentrated Growth Factor Membranes in Narrow Alveolar Ridge (Case Series).

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07534787
Acronym
CGF
Enrollment
10
Registered
2026-04-16
Start date
2026-05-01
Completion date
2026-12-30
Last updated
2026-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Narrow Alveolar Ridge, CGF Concentrated Growth Factor, Postoperative Pain, Implant Placement

Keywords

Ridge splitting, Dental implants, Concentrated growth factor (CGF), Bone density, Tissue biotype

Brief summary

This study aims to evaluate the tissue biotype and bone density around dental implants in patients with narrow alveolar ridge. Ridge splitting with simultaneous implant placement covered with concentrated growth factor (CGF) membranes will be performed. Clinical and radiographic evaluation will be done using periodontal probe and CBCT. Pain will also be assessed using visual analogue scale (VAS) during follow-up period.

Detailed description

This study is a case series conducted at the outpatient clinic of the Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Cairo University. It aims to evaluate the tissue biotype and bone density around dental implants in adult patients with narrow alveolar ridge. Alveolar ridge resorption and soft tissue shrinkage after tooth extraction represent a major problem affecting both aesthetics and function. Therefore, preserving alveolar bone and improving soft tissue conditions are essential for successful implant placement. The use of concentrated growth factor (CGF) membranes combined with ridge splitting and simultaneous implant placement may enhance healing, reduce postoperative pain, and improve tissue biotype and bone density. All patients will undergo clinical and radiographic assessment before the procedure. Preoperative CBCT will be used for surgical planning. Tissue thickness will be measured using a periodontal probe. During surgery, ridge splitting will be performed followed by implant placement, and CGF membranes will be applied over the grafted area. Autologous bone chips will be used for augmentation. Postoperative evaluation will include assessment of tissue biotype, bone density using CBCT, and pain using visual analogue scale (VAS). Follow-up will be carried out immediately after surgery and up to 4 months postoperatively.

Interventions

Patients with narrow alveolar ridge will undergo ridge splitting procedure using chisel to allow implant placement.

PROCEDUREDental implant placement

Intervention Description: Dental implants will be inserted simultaneously after ridge splitting in the prepared alveolar ridge.

CGF membranes will be prepared from patient venous blood and placed over the grafted area to enhance healing and tissue regeneration.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

\- Patients with narrow alveolar ridge indicated for implant placement Age between 20 and 50 years Good general health Patients with adequate oral hygiene

Exclusion criteria

* Patients with systemic diseases affecting bone healing Smokers Pregnant or lactating females Patients with poor oral hygiene Patients with history of radiation therapy in the head and neck region

Design outcomes

Primary

MeasureTime frameDescription
Pain (VAS score)1st day and 3rd day postoperativePain will be assessed using Visual Analogue Scale (VAS) ranging from 0 to 10.

Secondary

MeasureTime frameDescription
Tissue biotype thicknessImmediately postoperative and after 4 monthsTissue biotype will be assessed using a periodontal probe and measured in millimeters.

Countries

Egypt

Contacts

CONTACTTasneem Farrag Ayoub, Master
tasneem.farrag@dentistry.cu.edu.eg+201125888649
STUDY_CHAIRHesham Said Said, Professor

Cairo University

STUDY_DIRECTORAbdelmoez Mohamed El-Sharkawy, Associate professor

Cairo University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 17, 2026